Peripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationTransplantation, AutologousTransplantation, HomologousHematopoietic Stem Cell MobilizationBone Marrow TransplantationTransplantation ConditioningGraft vs Host DiseaseLeukapheresisGranulocyte Colony-Stimulating FactorHematologic NeoplasmsStem Cell TransplantationBlood Component RemovalAntigens, CD34MelphalanStem CellsHematopoietic Stem CellsCombined Modality TherapyGraft SurvivalCyclophosphamideBusulfanMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsTissue DonorsTreatment OutcomeMyeloablative AgonistsCord Blood Stem Cell TransplantationTransplantation ChimeraRecurrenceLymphoma, Non-HodgkinAntineoplastic Agents, AlkylatingEtoposideRemission InductionThiotepaHistocompatibilityBlood CellsPOEMS SyndromeWhole-Body IrradiationHistocompatibility TestingHematopoiesisDisease-Free SurvivalInfectionVidarabineBlood Cell CountIfosfamideTransplantation, IsogeneicImmunosuppressive AgentsRetrospective StudiesSalvage TherapyLeukemiaBlood DonorsAmyloidosisSurvival RateCytarabineVincristinePlatelet CountSurvival AnalysisHodgkin DiseaseCarmustineTime FactorsLeukemia, Myeloid, AcuteGraft vs Leukemia EffectAnemia, AplasticLymphomaCytomegalovirus InfectionsMyelodysplastic SyndromesNeoplasmsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphocyte DepletionBone Marrow PurgingBone MarrowImmunophenotypingFeasibility StudiesCytophagocytosisRecombinant ProteinsHistiocytosis, Non-Langerhans-CellDoxorubicinHematologic DiseasesEmbryonic Stem CellsFollow-Up StudiesFatal OutcomeBone Marrow DiseasesOpportunistic InfectionsLivedo ReticularisCyclosporineLeukocyte CountPrecursor Cell Lymphoblastic Leukemia-LymphomaLeukocytes, MononuclearHLA AntigensAdult Stem CellsCell SeparationFlow CytometryAntigens, CDProspective StudiesCarboplatinMesenchymal Stem Cell TransplantationPilot ProjectsImmunosuppressionBlood Group IncompatibilityImmunomagnetic Separation